Cenobamate
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Cenobamate. Cenobamate inhibits voltage-gated sodium currents, It is also a GABAA channel modulator. Fully referenced neurology checklist.
Pharmacology
- Cenobamate inhibits voltage-gated sodium currents
- It is also a GABAA channel modulator
Use
Locked: subscribe to see this section.
Indication
Locked: subscribe to see this section.
Dosing
Locked: subscribe to see this section.
Contraindications
Locked: subscribe to see this section.
Side effects
Locked: subscribe to see this section.
Acronym
Locked: subscribe to see this section.
References
- Keam SJ. Cenobamate: first approval. Drugs 2020; 80:73-78.
- Krauss GL, Klein P, Brandt C, et al. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. Lancet Neurol 2020; 19:38-48.
- Chung SS, French JA, Kowalski J, et al. Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures. Neurology 2020; 94:e2311-e2322.
- Makridis KL, Kaindl AM. Real-world experience with cenobamate: A systematic review and meta-analysis. Seizure 2023; 112:1-10.
- Rosenfeld WE, Ferrari L, Kamin M. Efficacy of cenobamate by focal seizure subtypes: post-hoc analysis of a phase 3, multicenter, open-label study. Epilepsy Res 2022; 183:106940.
- And 3 more. Subscribe to see the full list
